Pharmerica (PMC) Tops Q1 EPS by 2c; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
PharMerica Reports First Quarter 2017 Results
May 10, 2017 8:00 AM EDTStrong Financial Results
Reaffirms Annual 2017 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (the Corporation, PharMerica or the Company) (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and specialty pharmacy services, today reported its financial results for the first quarter ended March 31, 2017.
             1Q17 Results  ÂComparison to 1Q16
 ÂComparison to 4Q16
Revenue   $566.8 million   Increase of 8.1%   Increase of 6.1% Gross profit   $87.9 million   ... More